CCA
PTLA

Checchi Capital Advisers’s Portola Pharmaceuticals, Inc. PTLA Stock Holding History

Checchi Capital Advisers’s Portfolio PTLA Stock Details PTLA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-373
Closed -$9K – 1388
2016
Q2 		$9K Buy
373
+364
+4,044% +$8.99K ﹤0.01% 1323
2016
Q1 		$0 Buy
+9
New +$286 ﹤0.01% 1628

Other funds holding PTLA

Temasek Holdings
Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
SAM
Sectoral Asset Management Montreal, Quebec, Canada $143M AUM 102.52% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Checchi Capital Advisers's PTLA Position: Q3 2016 in Review

Checchi Capital Advisers sold out of Portola Pharmaceuticals, Inc. (PTLA) in Q3 2016, closing a stake of 373 shares — an estimated $9K sold.

Checchi Capital Advisers first reported a position in PTLA in Q1 2016 and held it in 2 quarters. The position peaked at $9K in Q2 2016. 151 funds tracked by Wall St. Rank hold PTLA as of Q3 2016.

  • Checchi Capital Advisers reported no remaining Portola Pharmaceuticals, Inc. position as of Q3 2016 after selling out during the quarter.
  • Checchi Capital Advisers sold 373 Portola Pharmaceuticals, Inc. shares in Q3 2016, an estimated $9K.
  • Checchi Capital Advisers first reported a position in Portola Pharmaceuticals, Inc. in Q1 2016 and held it in 2 quarters.
  • Checchi Capital Advisers's Portola Pharmaceuticals, Inc. position peaked at $9K in Q2 2016.
  • 151 funds tracked by Wall St. Rank held Portola Pharmaceuticals, Inc. as of Q3 2016.

Based on Checchi Capital Advisers's 13F filing for Q3 2016, filed 10 Nov 2016.